CARDIOVASCULAR RISK PREVALENCE IN HIGH RISK PRIMARY CARE PATIENTS NOT TREATED WITH LIPID-LOWERING TREATMENT IN FRANCE, RESULTS OF AN ONLINE STUDY

被引：1
|
作者：
Kownator, S. [1 ]
Ferrieres, J. [2 ]
Bruckert, E. [3 ]
Bonnelye, G. [4 ]
Thomas-delecourt, F. [5 ]
Delaage, P. H. [6 ]
Dallongeville, J. [7 ]
机构：
[1] Cabinet Cardiol, Thionville, France
[2] Toulouse Univ, Sch Med, Toulouse, France
[3] Hop La Pitie Salpetriere, Paris 13, France
[4] Kantar Hlth, Montrouge, France
[5] AstraZeneca, Rueil Malmaison, France
[6] AstraZeneca, Ruiel Malmaison, France
[7] Inst Pasteur, F-59019 Lille, France
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.853
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 50 条
  • [1] Cardiovascular risk profile in high risk primary care patients not treated with lipid-lowering treatment
    Dallongeville, J.
    Bruckert, E.
    Ferrieres, J.
    Delaage, P. H.
    Thomas-Delecourt, F.
    Bonnelye, G.
    Kownator, S.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 127 - 127
  • [2] Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
    Lis, Anna
    Lis, Paulina
    Lowicka, Weronika
    Grabarczyk, Malgorzata
    Wita, Michal
    Zarczynski, Piotr
    Zarczynska, Malgorzata
    Haberka, Maciej
    [J]. JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (08)
  • [3] Impact of lipid-lowering therapy on the prevalence of dyslipidaemia in patients at high-risk of cardiovascular events in UK primary care - a retrospective database study
    Jameson, K.
    Amber, V.
    D'Oca, K.
    Mills, D.
    Giles, A.
    Ambegaonkar, B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1228 - 1237
  • [4] Lipid-lowering treatment in patients at high cardiovascular risk discharged from an Italian hospital
    Spighi, Alessandro
    Tartagni, Elisa
    D'Addato, Sergio
    Dormi, Ada
    Borghi, Claudio
    [J]. JOURNAL OF CARDIOVASCULAR MEDICINE, 2013, 14 (04) : 270 - 275
  • [5] Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
    Roever, Leonardo
    Biondi-Zoccai, Giuseppe
    Rao, Sunil V.
    [J]. CLINICAL THERAPEUTICS, 2017, 39 (03) : 659 - 660
  • [6] Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients
    Egede, Rasmus
    Jensen, Lisette Okkels
    Hansen, Henrik Steen
    Antonsen, Lisbeth
    Hansen, Knud Norregaard
    Junker, Anders
    Thayssen, Per
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (03) : 376 - 379
  • [7] Cardiovascular risk and lipid-lowering drug therapy
    Stulnig, T.
    [J]. DIABETOLOGE, 2012, 8 (07): : 568 - 572
  • [8] Effectiveness of lipid-lowering therapy in primary care in France
    Van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    Yin, DD
    de Pouvourville, G
    [J]. VALUE IN HEALTH, 2003, 6 (06) : 643 - 643
  • [9] Effectiveness of lipid-lowering therapy in primary care in France
    Van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    de Pouvourville, G
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 319 - 320
  • [10] Effectiveness of lipid-lowering therapy in primary care in France
    van Ganse, E
    Moulin, P
    Bertrand, M
    Souchet, T
    Pietri, G
    Alemao, E
    Yin, D
    de Pouvourville, G
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 155 - 155
12345